On July 27, Fazan Leisheng tablets, an innovative anti-insomnia drug, debuted online at Meituan Drug Purchase. This is the first self-developed dual orexin receptor antagonist in China. It can be used to treat adult insomnia patients characterized by difficulty falling asleep or maintaining sleep. Traditional sleeping pills mostly work by broadly inhibiting the central nervous system, often causing problems such as drowsiness, dependency, and withdrawal reactions the next day. As a next-generation DORA drug, Fazan Raison tablets accurately inhibit excessive wakefulness signals by double blocking orexin receptors, do not damage the natural sleep structure, and help patients recover sleep close to their physiological state. According to Meituan drug purchase data, since the launch of the new generation of DORA sleeping pills, the compound growth rate of platform-related orders has remained in double digits, and users' demand for innovative sleep treatment plans is rapidly being released.

On July 27, Fazan Leisheng tablets, an innovative anti-insomnia drug, debuted online at Meituan Drug Purchase. This is the first self-developed dual orexin receptor antagonist in China. It can be used to treat adult insomnia patients characterized by difficulty falling asleep or maintaining sleep. Traditional sleeping pills mostly work by broadly inhibiting the central nervous system, often causing problems such as drowsiness, dependency, and withdrawal reactions the next day. As a next-generation DORA drug, Fazan Raison tablets accurately inhibit excessive wakefulness signals by double blocking orexin receptors, do not damage the natural sleep structure, and help patients recover sleep close to their physiological state. According to Meituan drug purchase data, since the launch of the new generation of DORA sleeping pills, the compound growth rate of platform-related orders has remained in double digits, and users' demand for innovative sleep treatment plans is rapidly being released.